Literature DB >> 26223954

[Sub-threshold prostate-specific antigen levels after resection of metachronous pulmonary metastases].

A Spek1, C Faber2, C Stief3.   

Abstract

Radical prostatectomy is a curative therapy for prostate cancer with a lifetime follow-up because there is a high risk of recurrence, especially in the first years of follow-up. In our case disseminated metachronous pulmonary metastases were detected by imaging 4 years after prostatectomy because of elevated levels of serum prostate-specific antigen (PSA). After complete resection of the thoracic metastases the PSA levels have remained below the detection threshold with a recurrence-free survival of 24 months. This case demonstrates that the resection of pulmonary metastases may also be useful for specific individual patients with prostate cancer.

Entities:  

Keywords:  Prostatectomy; Pulmonary metastases; Relapse; Resection, metastases; Survival, progression-free

Mesh:

Substances:

Year:  2015        PMID: 26223954     DOI: 10.1007/s00120-015-3923-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

Review 1.  [Update S3-guideline "colorectal cancer" 2008].

Authors:  W Schmiegel; A Reinacher-Schick; D Arnold; U Graeven; V Heinemann; R Porschen; J Riemann; C Rödel; R Sauer; M Wieser; W Schmitt; H-J Schmoll; T Seufferlein; I Kopp; C Pox
Journal:  Z Gastroenterol       Date:  2008-08       Impact factor: 2.000

2.  Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases.

Authors:  Ulrike Schick; Sandra Jorcano; Philippe Nouet; Michel Rouzaud; Hansjoerg Vees; Thomas Zilli; Osman Ratib; Damien C Weber; Raymond Miralbell
Journal:  Acta Oncol       Date:  2013-04-02       Impact factor: 4.089

3.  The role of resection of pulmonary metastases from prostate cancer: a case report and literature review.

Authors:  Christopher J D Wallis; John C English; S Larry Goldenberg
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

4.  Solitary lung metastasis after radical prostatectomy in presence of undetectable PSA.

Authors:  Pietro Pepe; Filippo Fraggetta; Francesco Tornabene; Maurizio Nicolosi; Francesco Aragona
Journal:  Arch Ital Urol Androl       Date:  2012-12

5.  [Imaging diagnostics of advanced prostate cancer].

Authors:  A Kretschmer; M Seitz; A Graser; C G Stief; D Tilki
Journal:  Urologe A       Date:  2013-04       Impact factor: 0.639

Review 6.  Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature.

Authors:  Piet Ost; Alberto Bossi; Karel Decaestecker; Gert De Meerleer; Gianluca Giannarini; R Jeffrey Karnes; Mack Roach; Alberto Briganti
Journal:  Eur Urol       Date:  2014-09-17       Impact factor: 20.096

Review 7.  Solitary pulmonary metastasis from prostate cancer with neuroendocrine differentiation: a case report and review of relevant cases from the literature.

Authors:  Toshiya Maebayashi; Katsumi Abe; Takuya Aizawa; Masakuni Sakaguchi; Naoya Ishibash; Shoko Fukushima; Taku Honma; Yoshiaki Kusumi; Tsuyoshi Matsui; Nozomu Kawata
Journal:  World J Surg Oncol       Date:  2015-05-07       Impact factor: 2.754

8.  Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer.

Authors:  Kamran A Ahmed; Brandon M Barney; Brian J Davis; Sean S Park; Eugene D Kwon; Kenneth R Olivier
Journal:  Front Oncol       Date:  2013-01-22       Impact factor: 6.244

9.  Pulmonary and chest wall metastasectomy in urogenital tumors: a single center experience and review of literature.

Authors:  Seyd Hossein Fattahi Masoum; Behzad Feizzdeh Kerigh; Alireza Goreifi
Journal:  Nephrourol Mon       Date:  2014-05-03

10.  Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial.

Authors:  Karel Decaestecker; Gert De Meerleer; Filip Ameye; Valerie Fonteyne; Bieke Lambert; Steven Joniau; Louke Delrue; Ignace Billiet; Wim Duthoy; Sarah Junius; Wouter Huysse; Nicolaas Lumen; Piet Ost
Journal:  BMC Cancer       Date:  2014-09-15       Impact factor: 4.430

View more
  2 in total

1.  [Uncommon manifestation of prostate cancer : Sister Mary Joseph's nodule].

Authors:  T Hansen; M Weckesser; M Schäfers; A Gunnemann
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

2.  [Metastasized urological malignancies : Is resection of the primary tumor or destruction using alternative procedures worthwhile?]

Authors:  Christian G Stief; Herbert Rübben
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.